doc. Mgr. Kamil Paruch, Ph.D.
Associate professor, Department of Chemistry
Correspondence Address:
Kotlářská 267/2, 611 37 Brno
Office: bldg. A08/322
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 5477 |
---|---|
E‑mail: |
Total number of publications: 148
2023
-
4-(1H-IMIDAZOL-5-YL)-1H-PYRROLO [2,3-B] PYRIDINES FOR USE IN THE TREATMENT OF LEUKAEMIAS, LYMPHOMAS AND SOLID TUMORS
Publisher: China National Intellectual Property Administration, state: China, patent's number: CN111936496, year: 2023
-
Convergent Assembly of the Tricyclic Labdane Core Enables Synthesis of Diverse Forskolin-like Molecules
Angewandte Chemie International Edition, year: 2023, volume: 62, edition: 1, DOI
-
Discovery of Potent and Exquisitely Selective Inhibitors of Kinase CK1 with Tunable Isoform Selectivity
Angewandte Chemie International Edition, year: 2023, volume: 62, edition: 11, DOI
-
Substituted aminothiazoles as inhibitors of nucleases
Publisher: United States Patent and Trademark Office, state: United States, patent's number: US11584742, year: 2023
-
Substituted aminothiazoles as inhibitors of nucleases
Publisher: Israel Patent Office, state: Israel, patent's number: IL277866, year: 2023
-
Substituted propanamides as inhibitors of nucleases
Publisher: IP Australia, state: Australia, patent's number: AU2019256672, year: 2023
2022
-
4-(1h- imidazol- 5- yl) -1h-pyrrolo [2, 3-b] pyridines for use in the treatment of leukaemias, lymphomas and solid tumors
Publisher: Canadian Intellectual Property Office, state: Canada, patent's number: CA3085967, year: 2022
-
4-(1h- imidazol- 5- yl) -1h-pyrrolo [2, 3-b] pyridines for use in the treatment of leukaemias, lymphomas and solid tumors
Publisher: European Patent Office, state: Germany, patent's number: EP3774795, year: 2022
-
4-(1H-imidazol-5-yl)-1H-pyrrolo[2, 3-b] pyridines for use in the treatment of leukaemias, lymphomas and solid tumors
Publisher: United States Patent and Trademark Office, state: United States, patent's number: US11498920, year: 2022
-
CDK11 regulates pre-mRNA splicing by phosphorylation ofSF3B1
NATURE, year: 2022, volume: 609, edition: 7928, DOI